Piñana, J., Heras, I., Aiello, T., García-Cadenas, I., Vazquez, L., Lopez-Jimenez, J., . . . Solano, C. (2023). Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients.
Citación estilo ChicagoPiñana, JL, et al. Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. 2023.
Cita MLAPiñana, JL, et al. Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. 2023.
Precaución: Estas citas no son 100% exactas.